GlaxoSmithKline Investments & Fund Profile

Overview

Science-led global healthcare company providing medicines and vaccines.

Founded

1929

Deals · 12mo

1

Links

Website LinkedIn X (Twitter)

Stage focus

Series B

Series C

Geographic focus

Canada

Switzerland

United States

Sector focus

Biotechnology

Health Care

Pharmaceutical

Investment portfolio

11rounds

LedParticipated

NAME	DATE	SIZE
LifeMine Therapeutics	Aug 2026Participated	$188 MSeries E
Asceneuron	Jul 2024Participated	$100 MSeries C
LifeMine Therapeutics	Mar 2022Participated	$175 MSeries C
Vir Biotechnology	Apr 2020Led	$250 MOther Equity
SpringWorks Therapeutics	Apr 2019Participated	$125 MSeries B
Atreca	Nov 2015Participated	$56 MSeries A
Bird Rock Bio	Mar 2014Participated	$15 MSeries B
Amicus Therapeutics	Dec 2013Participated	$40 MDebt
SetPoint Medical	Aug 2013Participated	$27 MOther Equity
Thrasos	Oct 2012Participated	$35 MOther Equity
Anacor Pharmaceutical	Jan 2009Participated	$50 MOther Equity
LifeMine Therapeutics	Aug 2026Participated	$188 MSeries E
Asceneuron	Jul 2024Participated	$100 MSeries C
LifeMine Therapeutics	Mar 2022Participated	$175 MSeries C
Vir Biotechnology	Apr 2020Led	$250 MOther Equity
SpringWorks Therapeutics	Apr 2019Participated	$125 MSeries B
Atreca	Nov 2015Participated	$56 MSeries A
Bird Rock Bio	Mar 2014Participated	$15 MSeries B
Amicus Therapeutics	Dec 2013Participated	$40 MDebt
SetPoint Medical	Aug 2013Participated	$27 MOther Equity
Thrasos	Oct 2012Participated	$35 MOther Equity
Anacor Pharmaceutical	Jan 2009Participated	$50 MOther Equity

11 Items

11

Items

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

GlaxoSmithKline: 11 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Series A	0	1
Series B	0	2
Series C+	0	3
Other Equity	1	3
Debt	0	1

Monthly Deal Activity

GlaxoSmithKline: 11 deals are recorded across 214 months. All available history
Month	Deals
Jan '09	1
Feb '09	0
Mar '09	0
Apr '09	0
May '09	0
Jun '09	0
Jul '09	0
Aug '09	0
Sep '09	0
Oct '09	0
Nov '09	0
Dec '09	0
Jan '10	0
Feb '10	0
Mar '10	0
Apr '10	0
May '10	0
Jun '10	0
Jul '10	0
Aug '10	0
Sep '10	0
Oct '10	0
Nov '10	0
Dec '10	0
Jan '11	0
Feb '11	0
Mar '11	0
Apr '11	0
May '11	0
Jun '11	0
Jul '11	0
Aug '11	0
Sep '11	0
Oct '11	0
Nov '11	0
Dec '11	0
Jan '12	0
Feb '12	0
Mar '12	0
Apr '12	0
May '12	0
Jun '12	0
Jul '12	0
Aug '12	0
Sep '12	0
Oct '12	1
Nov '12	0
Dec '12	0
Jan '13	0
Feb '13	0
Mar '13	0
Apr '13	0
May '13	0
Jun '13	0
Jul '13	0
Aug '13	1
Sep '13	0
Oct '13	0
Nov '13	0
Dec '13	1
Jan '14	0
Feb '14	0
Mar '14	1
Apr '14	0
May '14	0
Jun '14	0
Jul '14	0
Aug '14	0
Sep '14	0
Oct '14	0
Nov '14	0
Dec '14	0
Jan '15	0
Feb '15	0
Mar '15	0
Apr '15	0
May '15	0
Jun '15	0
Jul '15	0
Aug '15	0
Sep '15	0
Oct '15	0
Nov '15	1
Dec '15	0
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	0
May '16	0
Jun '16	0
Jul '16	0
Aug '16	0
Sep '16	0
Oct '16	0
Nov '16	0
Dec '16	0
Jan '17	0
Feb '17	0
Mar '17	0
Apr '17	0
May '17	0
Jun '17	0
Jul '17	0
Aug '17	0
Sep '17	0
Oct '17	0
Nov '17	0
Dec '17	0
Jan '18	0
Feb '18	0
Mar '18	0
Apr '18	0
May '18	0
Jun '18	0
Jul '18	0
Aug '18	0
Sep '18	0
Oct '18	0
Nov '18	0
Dec '18	0
Jan '19	0
Feb '19	0
Mar '19	0
Apr '19	1
May '19	0
Jun '19	0
Jul '19	0
Aug '19	0
Sep '19	0
Oct '19	0
Nov '19	0
Dec '19	0
Jan '20	0
Feb '20	0
Mar '20	0
Apr '20	1
May '20	0
Jun '20	0
Jul '20	0
Aug '20	0
Sep '20	0
Oct '20	0
Nov '20	0
Dec '20	0
Jan '21	0
Feb '21	0
Mar '21	0
Apr '21	0
May '21	0
Jun '21	0
Jul '21	0
Aug '21	0
Sep '21	0
Oct '21	0
Nov '21	0
Dec '21	0
Jan '22	0
Feb '22	0
Mar '22	1
Apr '22	0
May '22	0
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	0
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	0
Apr '23	0
May '23	0
Jun '23	0
Jul '23	0
Aug '23	0
Sep '23	0
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	1
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	0
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	1
Sep '26	0
Oct '26	0

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

GlaxoSmithKline: Health & Life Sciences is the largest displayed sector by deal count (11 deals). All available history
Sector	Deals
Health & Life Sciences	11
Consumer & Lifestyle	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

GlaxoSmithKline: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	0
$5M-$10M	0
$10M-$25M	1
$25M-$50M	3
$50M-$100M	2
$100M-$250M	4
$250M-$500M	1
$500M-$1B	0
$1B+	0

Deals By Geography

Top 3 of 3 regions; European countries are grouped as Europe.

GlaxoSmithKline: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
Region	Deals
United States	9
Europe	1
Canada	1

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

GlaxoSmithKline: 20 co-investors are shown, with SR One sharing 3 recorded deals. All available history
Co-investor	Shared deals
SR One	3
ARCH Venture Partners	2
Google Ventures	2
Invus	2
M Ventures	2
OrbiMed	2
3W Partners	1
5AM Ventures	1
Aberdare Ventures	1
Action Potential Venture Capital	1
Advanced Technology Ventures	1
Apposite Capital	1
Aravis	1
ArrowMark Partners	1
Bain Capital	1
Bezos Expeditions	1
Bill & Melinda Gates Foundation	1
Blue Pool Capital	1
Boston Scientific	1
Boxer Capital	1